Congressional inaction harms federally funded oncology research and our patients:

The time for the cancer community to act is now

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

On behalf of the millions of Americans with cancer, whose very lives depend on our nation’s investment in oncology research, we ask that you join us now in urging congressional lawmakers to do the right thing: pass robust funding for the National Institutes of Health and the National Cancer Institute.

Clinical trials that test new therapeutic agents are fueled by discovery science from many sources, including laboratories funded by NIH, direct sponsorship by pharmaceutical companies, and those arising from partner research groups throughout the world. 

Although the pharmaceutical industry plays an important role in developing new drugs, clinical oncology research funded by the U.S. government remains a particularly critical path for accelerating new therapies, providing transformative benefit to patients facing cancer.  

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Howard A. "Skip" Burris, III, MD, FACP, FASCO
Chair, Association for Clinical Oncology (ASCO)
Charles D. Blanke, MD, FASCO, FAWM
Chair, SWOG Cancer Research Network
Monica M. Bertagnolli, MD, FACS, FASCO
Chair, Alliance for Clinical Trials in Oncology
Peter J. O'Dwyer, MD
Co-Chairs, ECOG-ACRIN Cancer Research Group
Mitchell D. Schnall, MD, PhD
Co-Chairs, ECOG-ACRIN Cancer Research Group
Douglas S. Hawkins, MD
Group Chair, Children’s Oncology Group
Quynh-Thu Le, MD, FACR, FASTRO
Co-Chairs, NRG Oncology
Robert S. Mannel, MD
Co-Chairs, NRG Oncology
Norman Wolmark, MD, FACS, FRCSC
Co-Chairs, NRG Oncology
Janet Dancey, MD, FRCPC
Chair, Canadian Cancer Trials Group
Table of Contents

YOU MAY BE INTERESTED IN

Howard A. "Skip" Burris, III, MD, FACP, FASCO
Chair, Association for Clinical Oncology (ASCO)
Charles D. Blanke, MD, FASCO, FAWM
Chair, SWOG Cancer Research Network
Monica M. Bertagnolli, MD, FACS, FASCO
Chair, Alliance for Clinical Trials in Oncology
Peter J. O'Dwyer, MD
Co-Chairs, ECOG-ACRIN Cancer Research Group
Mitchell D. Schnall, MD, PhD
Co-Chairs, ECOG-ACRIN Cancer Research Group
Douglas S. Hawkins, MD
Group Chair, Children’s Oncology Group
Quynh-Thu Le, MD, FACR, FASTRO
Co-Chairs, NRG Oncology
Robert S. Mannel, MD
Co-Chairs, NRG Oncology
Norman Wolmark, MD, FACS, FRCSC
Co-Chairs, NRG Oncology
Janet Dancey, MD, FRCPC
Chair, Canadian Cancer Trials Group

Login